Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.24% |
$4,764
$1587.99 p/Share
|
Apr 05
2021 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.18% |
$1,748
$2.59 p/Share
|
Apr 05
2021 |
DNP
|
David J Vitale
Director |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 15.02% |
$49,500
$9.9 p/Share
|
Apr 05
2021 |
GALT
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 14.29% |
$10,200
$2.04 p/Share
|
Apr 05
2021 |
NMTR
|
Mark A Sirgo
Director |
BUY
Open market or private purchase
|
Direct | 300,000 Added 21.83% |
$300,000
$1.0 p/Share
|
Apr 05
2021 |
NMTR
|
John Temperato
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 100,000 Added 8.49% |
$100,000
$1.0 p/Share
|
Apr 05
2021 |
NMTR
|
Edward J Sitar
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 50,000 Added 21.8% |
$50,000
$1.0 p/Share
|
Apr 05
2021 |
VIRI
|
Gregory Scott Duncan
CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct | 15,675 Added 44.46% |
$96,715
$6.17 p/Share
|
Apr 05
2021 |
WINT
|
Craig Fraser
President and CEO |
BUY
Open market or private purchase
|
Direct | 1,000 Added 3.47% |
$2,580
$2.58 p/Share
|
Apr 05
2021 |
DYNT
|
Brian D. Baker
CEO & President |
BUY
Open market or private purchase
|
Direct | 3,239 Added 1.74% |
-
|
Apr 05
2021 |
DYNT
|
Provco Ventures 1 LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 32,564 Added 3.18% |
-
|
Apr 05
2021 |
DYNT
|
Erin S. Enright
Director |
BUY
Open market or private purchase
|
Indirect | 65,164 Added 4.46% |
-
|
Apr 05
2021 |
DYNT
|
Brian D. Baker
CEO & President |
BUY
Open market or private purchase
|
Direct | 4,571 Added 5.67% |
-
|
Apr 05
2021 |
DYNT
|
Stuart Essig
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 54,271 Added 3.47% |
-
|
Apr 05
2021 |
DYNT
|
Stuart Essig
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 10,893 Added 5.45% |
-
|
Apr 05
2021 |
RMESF
|
Richard Jeffs
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 36,539 Added 0.5% |
$5,481
$0.15 p/Share
|
Apr 05
2021 |
CZNC
|
Frank G Pellegrino |
BUY
Open market or private purchase
|
Direct | 299 Added 1.29% |
$7,176
$24.0 p/Share
|
Apr 05
2021 |
CZNC
|
Robert G Loughery |
BUY
Open market or private purchase
|
Direct | 207 Added 6.66% |
$4,968
$24.0 p/Share
|
Apr 05
2021 |
CZNC
|
Bobbi J Kilmer |
BUY
Open market or private purchase
|
Direct | 260 Added 3.11% |
$6,240
$24.0 p/Share
|
Apr 05
2021 |
CZNC
|
Timothy E Schoener |
BUY
Open market or private purchase
|
Direct | 208 Added 6.27% |
$4,992
$24.0 p/Share
|
Apr 05
2021 |
RDW
|
Crescent Park Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 57,098 Added 2.28% |
$593,248
$10.39 p/Share
|
Apr 05
2021 |
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 31,400 Added 0.08% |
$44,274
$1.41 p/Share
|
Apr 05
2021 |
PHX
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25,628 Added 0.47% |
$72,271
$2.82 p/Share
|
Apr 05
2021 |
SAIC
|
Prabu Natarajan
EVP, Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 3,000 Added 50.0% |
$252,930
$84.31 p/Share
|
Apr 05
2021 |
HHC
|
Allen J Model
Director |
BUY
Open market or private purchase
|
Direct | 4,300 Added 17.24% |
$417,831
$97.17 p/Share
|
Apr 05
2021 |
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 1,620 Added 0.08% |
$24,268
$14.98 p/Share
|
Apr 05
2021 |
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 1,620 Added 0.08% |
$24,268
$14.98 p/Share
|
Apr 05
2021 |
COUR
|
G Squared Equity Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300,000 Added 1.58% |
$9,900,000
$33.0 p/Share
|
Apr 05
2021 |
COUR
|
G Squared Equity Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300,000 Added 1.58% |
$9,900,000
$33.0 p/Share
|
Apr 05
2021 |
COUR
|
G Squared Equity Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300,000 Added 1.58% |
$9,900,000
$33.0 p/Share
|
Apr 05
2021 |
VYGR
|
Robert W. Hesslein
Senior VP & General Counsel |
BUY
Open market or private sale
|
Direct | 3,292 Added 2.9% |
$16,295
$4.95 p/Share
|
Apr 05
2021 |
OSG
|
Saltchuk Resources, Inc. |
BUY
Open market or private purchase
|
Direct | 720,216 Added 4.52% |
$1,505,251
$2.09 p/Share
|
Apr 05
2021 |
MBTCR
|
Nocturne Sponsor, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 450,000 Added 50.0% |
$4,500,000
$10.0 p/Share
|
Apr 05
2021 |
MBTCR
|
Ka Seng Ao
Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 450,000 Added 50.0% |
$4,500,000
$10.0 p/Share
|
Apr 05
2021 |
MBTCR
|
Henry Monzon
Chairman and CEO |
BUY
Open market or private purchase
|
Indirect | 450,000 Added 50.0% |
$4,500,000
$10.0 p/Share
|
Apr 05
2021 |
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.41% |
$8,440
$16.88 p/Share
|
Apr 05
2021 |
GNPX
|
Brent M Longnecker
Director |
BUY
Open market or private purchase
|
Direct | 15,000 Added 50.0% |
$62,250
$4.15 p/Share
|
Apr 05
2021 |
MTEM
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct | 200,000 Added 2.35% |
$1,888,000
$9.44 p/Share
|
Apr 05
2021 |
ATNX
|
Kim Campbell
Director |
BUY
Open market or private purchase
|
Direct | 8,250 Added 50.0% |
$36,465
$4.42 p/Share
|
Apr 05
2021 |
APEN
|
Neil Gagnon
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 303 Added 0.08% |
$1,660
$5.48 p/Share
|
Apr 05
2021 |
TYME
|
Jan M Van Tornout
Acting Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 1,317 Added 50.0% |
$2,436
$1.85 p/Share
|
Apr 05
2021 |
ILAL
|
Jason Sunstein
Vice President and CFO |
BUY
Open market or private purchase
|
Direct | 46,000 Added 1.08% |
$63,940
$1.39 p/Share
|
Apr 04
2021 |
IMH
|
Rhp Trust, Dated May 31, 2011
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 4,172 Added 0.12% |
$8,386
$2.01 p/Share
|
Apr 01
2021 |
IMH
|
Richard H. Pickup
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,172 Added 0.12% |
$8,386
$2.01 p/Share
|
Apr 01
2021 |
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.41% |
$8,315
$16.63 p/Share
|
Apr 01
2021 |
OHI
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct | 500 Added 2.62% |
$18,540
$37.08 p/Share
|
Apr 01
2021 |
UTF
|
Ramona Lynn Rogers Windsor |
BUY
Open market or private purchase
|
Direct | 175 Added 50.0% |
$4,935
$28.2 p/Share
|
Apr 01
2021 |
PTA
|
Ramona Lynn Rogers Windsor |
BUY
Open market or private purchase
|
Direct | 200 Added 50.0% |
$4,980
$24.9 p/Share
|
Apr 01
2021 |
EZPW
|
Jason A. Kulas
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.88% |
$5,050
$5.05 p/Share
|
Apr 01
2021 |
RFI
|
Ramona Lynn Rogers Windsor
Director |
BUY
Open market or private purchase
|
Direct | 300 Added 50.0% |
$4,455
$14.85 p/Share
|
Apr 01
2021 |